key: cord-0799886-zpqj7y0z
authors: Bartas, Martin; Volná, Adriana; Brázda, Václav; Červeň, Jiří; Pečinka, Petr
title: Unheeded SARS-CoV-2 protein? Look deep into negative-sense RNA
date: 2020-11-27
journal: bioRxiv
DOI: 10.1101/2020.11.27.400788
sha: af4d61dec5bc9429401255e309f8ab00fe973cbe
doc_id: 799886
cord_uid: zpqj7y0z

SARS-CoV-2 is a novel ssRNA+ virus from the Coronaviridae family, which has caused the global COVID-19 pandemic. The genome of SARS-CoV-2 is one of the largest of RNA viruses, comprising of 26 known protein-coding loci. This study aimed to explore the coding potential of negative-strand RNA intermediate for its potential to contain additional protein coding-loci. Surprisingly, we have found several putative ORFs and one brandt new functional SARS-CoV-2 protein-coding loci and called it Avo1 (Ambient viral ORF1). This sequence is located on negative-sense RNA intermediate and bona fide coding for 81 amino acid residues long protein and contains strong Kozak sequence for translation on eukaryotic ribosomes. In silico translated protein Avo1 has a predominantly alpha-helical structure. The existence of Avo1 gene is supported also by its evolutionarily and structural conservation in RaTG13 bat coronavirus. The nucleotide sequence of Avo1 also contains a unique SREBP2 binding site which is closely related to the so-called “cytokine storm” in severe COVID-19 patients. Altogether, our results suggest the existence of still undescribed SARS-CoV-2 protein, which may play an important role in the viral lifecycle and COVID-19 pathogenesis.

Coronavirus SARS-CoV-2, as a causative agent of COVID-19 disease, is intensively studied worldwide. It is generally considered that the SARS-CoV-2 genome is coding for 16 non-structural proteins (NSP1-16), 4 structural proteins (surface glycoprotein, membrane glycoprotein, envelope protein, nucleocapsid phosphoprotein), and 6 -9 "accessory factors" (still designated as "open reading frames", ORFs) (Gordon et al. 2020) . The length of the SARS-CoV-2 proteins varied from 1945 aa to 13 aa (Huang et al. 2020; Li et al. 2020; Helmy et al. 2020) . The shortest SARS-CoV-2 protein has only 13 aa (nsp11) and its function is unknown (Chen, Liu, a Guo 2020), followed by ORF10 (38 aa), ORF7b (43 aa), ORF6 (61 aa), and envelope protein (75 aa) (Wu et al. 2020) . The longest SARS-CoV-2 protein is a multidomain protein nsp3 (1945 aa) (Helmy et al. 2020 ). All to date described SARS-CoV-2 proteins are coded by positive-sense viral RNA strand. Overall, positive-sense RNA viruses are generally accepted to encode proteins solely on the positive strand, but in the current work by Dinan et al., they demonstrated that also negative-sense viral RNA strand has the potential to be protein-coding (Dinan et al. 2020) . We have decided to inspect the negative-sense intermediate viral RNA strand of SARS-CoV-2 and look for new potential ORFs. As an indicator for in vivo validity, we have chosen a combination of complementary bioinformatics approaches, e.g. the presence of so-called Kozak sequence, which is considered strong supportive evidence for being translated on host ribosomes (Gong et al. 2014) , transcription factor binding site analysis, homology search, and 3D structure prediction. Our analyses propose a novel SARS-CoV-2 ORF, which has a high probability to be translated in host cells.

The SARS-CoV-2 reference genome (NC_045512.2) was searched by NCBI ORFfinder (https://www.ncbi.nlm.nih.gov/orffinder/), to predict all potential ORFs longer than 200 nucleotides. We have focused especially on the negative strand intermediate (i.e. frames -1, -2, and -3). Using ATG pr web-based tool (https://atgpr.dbcls.jp/) (Salamov, Nishikawa, a Swindells 1998) , we have inspected, if they contain so-called Kozak sequence, which is considered an important signal in the 5´ end of mRNAs to be translated on eukaryotic ribosomes (Noderer et al. 2014) . To compute Mw and isoelectric point, we used the Expasy Compute pI/Mw tool (https://web.expasy.org/compute_pi/) (Gasteiger et al. 2005) . For the transcription factor binding site analysis, the RegRNA 2.0. webserver was used (Chang et al. 2013) . To find possible domain homologs we used NCBI´s Conserved Domains Database (CDD) webserver (Marchler-Bauer et al. 2015) with an E-value cut-off set to 10. For ab initio structural modeling, the QUARK tool was used (Xu a Zhang 2012) and the resulting structures were visualized within UCSC Chimera 1.15 workflow (Pettersen et al. 2004) . Supplementary materials contain all nucleotide and predicted protein sequences (SM1). Predicted PDB structures are enclosed in SM2. CDD domain hits are included in SM3.

We have predicted all putative SARS-CoV-2 ORFs longer than 200 nucleotides, resulting in a set of 8 protein candidates (all ORFs are enclosed in SM1, the longest was 303 nt long, and the shortest 201 nt in size). Then we have inspected if they contain the so-called Kozak sequence. We have found one highly promising candidate locus and called it Avo1 (Ambient viral ORF1). Avo1 nucleotide sequence (Figure 1 Top) contains a very wellconserved Kozak signal in the form of RYMRMVAUGGC (Noderer et al. 2014) , which is a nucleic acid motif that functions as the protein translation initiation site in most mammalian mRNA transcripts (Noderer et al. 2014 ). The strongest Kozak signals found in the SARS-CoV-2 genome are depicted in Figure 1 Bottom (five of six Kozak signals are located in RNA+ strand, one is located on the RNA-strand).

Avo1 locus is situated on nucleotide positions 422 -667 of the reference SARS-CoV-2 genome (NC_045512.2) and putative protein is translated in reading frame -2 (i.e. only from negative-sense SARS-CoV-2 RNA intermediate). Protein product would be 81 amino acid residues long and its molecular weight was computed to be 9586.06 Da with an isoelectric point (pI) 9.22. Interestingly, the proposed Avo1 gene contains 12 nt long SREBP2 binding site (Figure 1 Top). Recently it was found that "COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm" . It was found that the SARS-CoV-2 transcriptome is very diverse and rich ) and therefore, it is likely that also SARS-CoV-2 proteome will follow this trend and still unheeded viral proteins or protein variants wait for its discovery. Every newly described SARS-CoV-2 protein (and its host interacting proteins) could be a potential target for a drug repurposing or development of novel therapies (Gordon et al. 2020) , for instance it was found, that SARS-CoV-2 accessory proteins ORF6 and ORF8 inhibit type I interferon signaling pathway, and thus play a critical role in innate immune suppression during viral infection (Li et al. 2020) . Altogether, our results suggest the existence of a still undescribed SARS-CoV-2 protein, which may play an important role in the viral lifecycle and COVID-19 pathogenesis.

A Case for a Negative-Strand Coding Sequence in a Group of Positive-Sense RNA Viruses

Protein identification and analysis tools on the ExPASy server

Computational Analysis and Mapping of Novel Open Reading Frames in Influenza A Viruses

A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug Repurposing

The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control

Structural and Functional Properties of SARS-CoV-2 Spike Protein: Potential Antivirus Drug Development for COVID-19

An enhanced computational platform for investigating the roles of regulatory RNA and for identifying functional RNA motifs

Emerging Coronaviruses: Genome Structure, Replication, and Pathogenesis

The Architecture of SARS-CoV-2 Transcriptome

COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm

The ORF6, ORF8 and Nucleocapsid Proteins of SARS-CoV-2 Inhibit Type I Interferon Signaling Pathway

CDD: NCBI's conserved domain database

Quantitative analysis of mammalian translation initiation sites by FACS-seq

UCSF Chimera-a visualization system for exploratory research and analysis

Assessing Protein Coding Region Integrity in CDNA Sequencing Projects

A new coronavirus associated with human respiratory disease in China

Ab initio protein structure assembly using continuous structure fragments and optimized knowledge-based force field

We would like to thank our institution, the University of Ostrava, for an inspiring working environment and academic freedom.

M.B. carried out most of the analyses and wrote the manuscript, A.V. has conceived the presented idea and help with data curation, V.B. and J.C. have contributed to writing and revisions, P.P. supervised the work.